APO Research
Talk to an analyst

APO RESEARCH · REPORT

Drugs Produced by Fermentation Engineering

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Drugs Produced by Fermentation Engineering Market Analysis and Forecast 2026-2032

29 December 2025196 pages

Choose your research edition.

Industry ResearchDrugs Produced by Fermentation Engineering Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Drugs Produced by Fermentation Engineering Industry Growth and Trends Forecast to 2032100 pages · $3,450 USDMarket StructureGlobal Drugs Produced by Fermentation Engineering Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Drugs Produced by Fermentation Engineering Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Drugs Produced by Fermentation Engineering Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global Drugs Produced by Fermentation Engineering market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Drugs Produced by Fermentation Engineering is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Drugs Produced by Fermentation Engineering is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Drugs Produced by Fermentation Engineering is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Drugs Produced by Fermentation Engineering is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Drugs Produced by Fermentation Engineering include Changchun GeneScience Pharmaceutical, Tonghua Dongbao Pharmaceutical, Sichuan Kelun Pharmaceutical, CSPC Pharmaceutical Group, Shanghai Shyndec Pharmaceutical, Shanghai Fosun Pharmaceutical, 3SBio Inc, United Laboratories International Holdings and Shandong Kexing Bioproducts, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Drugs Produced by Fermentation Engineering, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Drugs Produced by Fermentation Engineering, also provides the revenue of main regions and countries. Of the upcoming market potential for Drugs Produced by Fermentation Engineering, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Drugs Produced by Fermentation Engineering revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Drugs Produced by Fermentation Engineering market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Drugs Produced by Fermentation Engineering revenue, projected growth trends, production technology, application and end-user industry.

Drugs Produced by Fermentation Engineering Segment by Company

Changchun GeneScience Pharmaceutical

Tonghua Dongbao Pharmaceutical

Sichuan Kelun Pharmaceutical

CSPC Pharmaceutical Group

Shanghai Shyndec Pharmaceutical

Shanghai Fosun Pharmaceutical

3SBio Inc

United Laboratories International Holdings

Shandong Kexing Bioproducts

Joincare Pharmaceutical Group

North China Pharma

Harbin Pharmaceutical Group

Gan and Lee Pharmaceuticals

Anhui Anke Biotechnology

Drugs Produced by Fermentation Engineering Segment by Type

Monoclonal Antibodies

Antibiotic

Human Growth Hormone

Pharmaceutical Amino Acids

Insulin

Others

Drugs Produced by Fermentation Engineering Segment by Application

Hospital

Clinic

Other

Drugs Produced by Fermentation Engineering Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Drugs Produced by Fermentation Engineering market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Drugs Produced by Fermentation Engineering and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Drugs Produced by Fermentation Engineering.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Drugs Produced by Fermentation Engineering in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Drugs Produced by Fermentation Engineering company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Drugs Produced by Fermentation Engineering revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Drugs Produced by Fermentation Engineering Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Monoclonal Antibodies Major Player Table 3. Antibiotic Major Player Table 4. Human Growth Hormone Major Player Table 5. Pharmaceutical Amino Acids Major Player Table 6. Insulin Major Player Table 7. Others Major Player Table 8. Global Drugs Produced by Fermentation Engineering Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 9. Hospital Major Player Table 10. Clinic Major Player Table 11. Other Major Player Table 12. Drugs Produced by Fermentation Engineering Industry Trends Table 13. Drugs Produced by Fermentation Engineering Industry Drivers Table 14. Drugs Produced by Fermentation Engineering Industry Opportunities and Challenges Table 15. Drugs Produced by Fermentation Engineering Industry Restraints Table 16. Global Drugs Produced by Fermentation Engineering Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 17. Global Drugs Produced by Fermentation Engineering Market Size by Region (2021-2026) & (US$ Million) Table 18. Global Drugs Produced by Fermentation Engineering Market Share by Region (2021-2026) Table 19. Global Drugs Produced by Fermentation Engineering Market Size by Region (2027-2032) & (US$ Million) Table 20. Global Drugs Produced by Fermentation Engineering Market Share by Region (2027-2032) Table 21. Global Drugs Produced by Fermentation Engineering Revenue by Players (US$ Million) & (2021-2026) Table 22. Global Drugs Produced by Fermentation Engineering Revenue Market Share by Players (2021-2026) Table 23. Global Drugs Produced by Fermentation Engineering Key Players Ranking, 2024 VS 2025 VS 2026 Table 24. Global Drugs Produced by Fermentation Engineering Key Players Headquarters & Area Served Table 25. Global Drugs Produced by Fermentation Engineering Players, Product Type & Application Table 26. Global Drugs Produced by Fermentation Engineering Players Establishment Date Table 27. Global Players Market Concentration Ratio (CR5 and HHI) Table 28. Global Drugs Produced by Fermentation Engineering by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 29. Global Drugs Produced by Fermentation Engineering Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Drugs Produced by Fermentation Engineering Revenue by Type (2021-2026) & (US$ Million) Table 31. Global Drugs Produced by Fermentation Engineering Revenue by Type (2027-2032) & (US$ Million) Table 32. Global Drugs Produced by Fermentation Engineering Revenue Market Share by Type (2021-2026) Table 33. Global Drugs Produced by Fermentation Engineering Revenue Market Share by Type (2027-2032) Table 34. Global Drugs Produced by Fermentation Engineering Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Drugs Produced by Fermentation Engineering Revenue by Application (2021-2026) & (US$ Million) Table 36. Global Drugs Produced by Fermentation Engineering Revenue by Application (2027-2032) & (US$ Million) Table 37. Global Drugs Produced by Fermentation Engineering Revenue Market Share by Application (2021-2026) Table 38. Global Drugs Produced by Fermentation Engineering Revenue Market Share by Application (2027-2032) Table 39. Changchun GeneScience Pharmaceutical Company Information Table 40. Changchun GeneScience Pharmaceutical Business Overview Table 41. Changchun GeneScience Pharmaceutical Drugs Produced by Fermentation Engineering Revenue and Gross Margin (US$ Million) & (2021-2026) Table 42. Changchun GeneScience Pharmaceutical Drugs Produced by Fermentation Engineering Product Portfolio Table 43. Changchun GeneScience Pharmaceutical Recent Development Table 44. Tonghua Dongbao Pharmaceutical Company Information Table 45. Tonghua Dongbao Pharmaceutical Business Overview Table 46. Tonghua Dongbao Pharmaceutical Drugs Produced by Fermentation Engineering Revenue and Gross Margin (US$ Million) & (2021-2026) Table 47. Tonghua Dongbao Pharmaceutical Drugs Produced by Fermentation Engineering Product Portfolio Table 48. Tonghua Dongbao Pharmaceutical Recent Development Table 49. Sichuan Kelun Pharmaceutical Company Information Table 50. Sichuan Kelun Pharmaceutical Business Overview Table 51. Sichuan Kelun Pharmaceutical Drugs Produced by Fermentation Engineering Revenue and Gross Margin (US$ Million) & (2021-2026) Table 52. Sichuan Kelun Pharmaceutical Drugs Produced by Fermentation Engineering Product Portfolio Table 53. Sichuan Kelun Pharmaceutical Recent Development Table 54. CSPC Pharmaceutical Group Company Information Table 55. CSPC Pharmaceutical Group Business Overview Table 56. CSPC Pharmaceutical Group Drugs Produced by Fermentation Engineering Revenue and Gross Margin (US$ Million) & (2021-2026) Table 57. CSPC Pharmaceutical Group Drugs Produced by Fermentation Engineering Product Portfolio Table 58. CSPC Pharmaceutical Group Recent Development Table 59. Shanghai Shyndec Pharmaceutical Company Information Table 60. Shanghai Shyndec Pharmaceutical Business Overview Table 61. Shanghai Shyndec Pharmaceutical Drugs Produced by Fermentation Engineering Revenue and Gross Margin (US$ Million) & (2021-2026) Table 62. Shanghai Shyndec Pharmaceutical Drugs Produced by Fermentation Engineering Product Portfolio Table 63. Shanghai Shyndec Pharmaceutical Recent Development Table 64. Shanghai Fosun Pharmaceutical Company Information Table 65. Shanghai Fosun Pharmaceutical Business Overview Table 66. Shanghai Fosun Pharmaceutical Drugs Produced by Fermentation Engineering Revenue and Gross Margin (US$ Million) & (2021-2026) Table 67. Shanghai Fosun Pharmaceutical Drugs Produced by Fermentation Engineering Product Portfolio Table 68. Shanghai Fosun Pharmaceutical Recent Development Table 69. 3SBio Inc Company Information Table 70. 3SBio Inc Business Overview Table 71. 3SBio Inc Drugs Produced by Fermentation Engineering Revenue and Gross Margin (US$ Million) & (2021-2026) Table 72. 3SBio Inc Drugs Produced by Fermentation Engineering Product Portfolio Table 73. 3SBio Inc Recent Development Table 74. United Laboratories International Holdings Company Information Table 75. United Laboratories International Holdings Business Overview Table 76. United Laboratories International Holdings Drugs Produced by Fermentation Engineering Revenue and Gross Margin (US$ Million) & (2021-2026) Table 77. United Laboratories International Holdings Drugs Produced by Fermentation Engineering Product Portfolio Table 78. United Laboratories International Holdings Recent Development Table 79. Shandong Kexing Bioproducts Company Information Table 80. Shandong Kexing Bioproducts Business Overview Table 81. Shandong Kexing Bioproducts Drugs Produced by Fermentation Engineering Revenue and Gross Margin (US$ Million) & (2021-2026) Table 82. Shandong Kexing Bioproducts Drugs Produced by Fermentation Engineering Product Portfolio Table 83. Shandong Kexing Bioproducts Recent Development Table 84. Joincare Pharmaceutical Group Company Information Table 85. Joincare Pharmaceutical Group Business Overview Table 86. Joincare Pharmaceutical Group Drugs Produced by Fermentation Engineering Revenue and Gross Margin (US$ Million) & (2021-2026) Table 87. Joincare Pharmaceutical Group Drugs Produced by Fermentation Engineering Product Portfolio Table 88. Joincare Pharmaceutical Group Recent Development Table 89. North China Pharma Company Information Table 90. North China Pharma Business Overview Table 91. North China Pharma Drugs Produced by Fermentation Engineering Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 92. North China Pharma Drugs Produced by Fermentation Engineering Product Portfolio Table 93. North China Pharma Recent Development Table 94. Harbin Pharmaceutical Group Company Information Table 95. Harbin Pharmaceutical Group Business Overview Table 96. Harbin Pharmaceutical Group Drugs Produced by Fermentation Engineering Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 97. Harbin Pharmaceutical Group Drugs Produced by Fermentation Engineering Product Portfolio Table 98. Harbin Pharmaceutical Group Recent Development Table 99. Gan and Lee Pharmaceuticals Company Information Table 100. Gan and Lee Pharmaceuticals Business Overview Table 101. Gan and Lee Pharmaceuticals Drugs Produced by Fermentation Engineering Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 102. Gan and Lee Pharmaceuticals Drugs Produced by Fermentation Engineering Product Portfolio Table 103. Gan and Lee Pharmaceuticals Recent Development Table 104. Anhui Anke Biotechnology Company Information Table 105. Anhui Anke Biotechnology Business Overview Table 106. Anhui Anke Biotechnology Drugs Produced by Fermentation Engineering Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 107. Anhui Anke Biotechnology Drugs Produced by Fermentation Engineering Product Portfolio Table 108. Anhui Anke Biotechnology Recent Development Table 109. North America Drugs Produced by Fermentation Engineering Revenue by Type (2021-2026) & (US$ Million) Table 110. North America Drugs Produced by Fermentation Engineering Revenue by Type (2027-2032) & (US$ Million) Table 111. North America Drugs Produced by Fermentation Engineering Revenue by Application (2021-2026) & (US$ Million) Table 112. North America Drugs Produced by Fermentation Engineering Revenue by Application (2027-2032) & (US$ Million) Table 113. North America Drugs Produced by Fermentation Engineering Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 114. North America Drugs Produced by Fermentation Engineering Revenue by Country (2021-2026) & (US$ Million) Table 115. North America Drugs Produced by Fermentation Engineering Revenue by Country (US$ Million) & (2027-2032) Table 116. Europe Drugs Produced by Fermentation Engineering Revenue by Type (2021-2026) & (US$ Million) Table 117. Europe Drugs Produced by Fermentation Engineering Revenue by Type (2027-2032) & (US$ Million) Table 118. Europe Drugs Produced by Fermentation Engineering Revenue by Application (2021-2026) & (US$ Million) Table 119. Europe Drugs Produced by Fermentation Engineering Revenue by Application (2027-2032) & (US$ Million) Table 120. Europe Drugs Produced by Fermentation Engineering Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 121. Europe Drugs Produced by Fermentation Engineering Revenue by Country (2021-2026) & (US$ Million) Table 122. Europe Drugs Produced by Fermentation Engineering Revenue by Country (US$ Million) & (2027-2032) Table 123. China Drugs Produced by Fermentation Engineering Revenue by Type (2021-2026) & (US$ Million) Table 124. China Drugs Produced by Fermentation Engineering Revenue by Type (2027-2032) & (US$ Million) Table 125. China Drugs Produced by Fermentation Engineering Revenue by Application (2021-2026) & (US$ Million) Table 126. China Drugs Produced by Fermentation Engineering Revenue by Application (2027-2032) & (US$ Million) Table 127. Asia Drugs Produced by Fermentation Engineering Revenue by Type (2021-2026) & (US$ Million) Table 128. Asia Drugs Produced by Fermentation Engineering Revenue by Type (2027-2032) & (US$ Million) Table 129. Asia Drugs Produced by Fermentation Engineering Revenue by Application (2021-2026) & (US$ Million) Table 130. Asia Drugs Produced by Fermentation Engineering Revenue by Application (2027-2032) & (US$ Million) Table 131. Asia Drugs Produced by Fermentation Engineering Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 132. Asia Drugs Produced by Fermentation Engineering Revenue by Region (US$ Million) & (2021-2026) Table 133. Asia Drugs Produced by Fermentation Engineering Revenue by Region (US$ Million) & (2027-2032) Table 134. SAMEA Drugs Produced by Fermentation Engineering Revenue by Type (2021-2026) & (US$ Million) Table 135. SAMEA Drugs Produced by Fermentation Engineering Revenue by Type (2027-2032) & (US$ Million) Table 136. SAMEA Drugs Produced by Fermentation Engineering Revenue by Application (2021-2026) & (US$ Million) Table 137. SAMEA Drugs Produced by Fermentation Engineering Revenue by Application (2027-2032) & (US$ Million) Table 138. SAMEA Drugs Produced by Fermentation Engineering Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 139. SAMEA Drugs Produced by Fermentation Engineering Revenue by Country (2021-2026) & (US$ Million) Table 140. SAMEA Drugs Produced by Fermentation Engineering Revenue by Country (US$ Million) & (2027-2032) Table 141. Research Programs/Design for This Report Table 142. Authors List of This Report Table 143. Secondary Sources Table 144. Primary Sources List of Figures Figure 1. Drugs Produced by Fermentation Engineering Image Figure 2. Global Drugs Produced by Fermentation Engineering Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Drugs Produced by Fermentation Engineering Market Size Share 2021 VS 2025 VS 2032 Figure 4. Monoclonal Antibodies Image Figure 5. Antibiotic Image Figure 6. Human Growth Hormone Image Figure 7. Pharmaceutical Amino Acids Image Figure 8. Insulin Image Figure 9. Others Image Figure 10. Global Drugs Produced by Fermentation Engineering Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 11. Global Drugs Produced by Fermentation Engineering Market Size Share 2021 VS 2025 VS 2032 Figure 12. Hospital Image Figure 13. Clinic Image Figure 14. Other Image Figure 15. Global Drugs Produced by Fermentation Engineering Market Size (US$ Million) & (2021-2032) Figure 16. Global Drugs Produced by Fermentation Engineering Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 17. Global Drugs Produced by Fermentation Engineering Market Share by Region: 2021 VS 2025 VS 2032 Figure 18. Global Drugs Produced by Fermentation Engineering Players Revenue Share Top 10 and Top 5 in 2025 Figure 19. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 20. Global Drugs Produced by Fermentation Engineering Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Drugs Produced by Fermentation Engineering Revenue Market Share 2021 VS 2025 VS 2032 Figure 22. Global Drugs Produced by Fermentation Engineering Revenue Market Share by Type (2021-2032) Figure 23. Global Drugs Produced by Fermentation Engineering Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Drugs Produced by Fermentation Engineering Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 25. Global Drugs Produced by Fermentation Engineering Revenue Market Share by Application (2021-2032) Figure 26. North America Drugs Produced by Fermentation Engineering Revenue YoY Growth (2021-2032) & (US$ Million) Figure 27. North America Drugs Produced by Fermentation Engineering Revenue Share by Type (2021-2032) Figure 28. North America Drugs Produced by Fermentation Engineering Revenue Share by Application (2021-2032) Figure 29. North America Drugs Produced by Fermentation Engineering Revenue Share by Country (2021-2032) Figure 30. United States Drugs Produced by Fermentation Engineering Revenue YoY Growth (US$ Million) & (2021-2032) Figure 31. Canada Drugs Produced by Fermentation Engineering Revenue YoY Growth (US$ Million) & (2021-2032) Figure 32. Mexico Drugs Produced by Fermentation Engineering Revenue YoY Growth (US$ Million) & (2021-2032) Figure 33. Europe Drugs Produced by Fermentation Engineering Revenue YoY Growth (2021-2032) & (US$ Million) Figure 34. Europe Drugs Produced by Fermentation Engineering Revenue Share by Type (2021-2032) Figure 35. Europe Drugs Produced by Fermentation Engineering Revenue Share by Application (2021-2032) Figure 36. Europe Drugs Produced by Fermentation Engineering Revenue Share by Country (2021-2032) Figure 37. Germany Drugs Produced by Fermentation Engineering Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. France Drugs Produced by Fermentation Engineering Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. U.K. Drugs Produced by Fermentation Engineering Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Italy Drugs Produced by Fermentation Engineering Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Spain Drugs Produced by Fermentation Engineering Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. Russia Drugs Produced by Fermentation Engineering Revenue YoY Growth (US$ Million) & (2021-2032) Figure 43. Netherlands Drugs Produced by Fermentation Engineering Revenue YoY Growth (US$ Million) & (2021-2032) Figure 44. Nordic Countries Drugs Produced by Fermentation Engineering Revenue YoY Growth (US$ Million) & (2021-2032) Figure 45. China Drugs Produced by Fermentation Engineering Revenue YoY Growth (2021-2032) & (US$ Million) Figure 46. China Drugs Produced by Fermentation Engineering Revenue Share by Type (2021-2032) Figure 47. China Drugs Produced by Fermentation Engineering Revenue Share by Application (2021-2032) Figure 48. Asia Drugs Produced by Fermentation Engineering Revenue YoY Growth (2021-2032) & (US$ Million) Figure 49. Asia Drugs Produced by Fermentation Engineering Revenue Share by Type (2021-2032) Figure 50. Asia Drugs Produced by Fermentation Engineering Revenue Share by Application (2021-2032) Figure 51. Asia Drugs Produced by Fermentation Engineering Revenue Share by Region (2021-2032) Figure 52. Japan Drugs Produced by Fermentation Engineering Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. South Korea Drugs Produced by Fermentation Engineering Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. India Drugs Produced by Fermentation Engineering Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. Australia Drugs Produced by Fermentation Engineering Revenue YoY Growth (US$ Million) & (2021-2032) Figure 56. Taiwan Drugs Produced by Fermentation Engineering Revenue YoY Growth (US$ Million) & (2021-2032) Figure 57. Southeast Asia Drugs Produced by Fermentation Engineering Revenue YoY Growth (US$ Million) & (2021-2032) Figure 58. SAMEA Drugs Produced by Fermentation Engineering Revenue YoY Growth (2021-2032) & (US$ Million) Figure 59. SAMEA Drugs Produced by Fermentation Engineering Revenue Share by Type (2021-2032) Figure 60. SAMEA Drugs Produced by Fermentation Engineering Revenue Share by Application (2021-2032) Figure 61. SAMEA Drugs Produced by Fermentation Engineering Revenue Share by Country (2021-2032) Figure 62. Brazil Drugs Produced by Fermentation Engineering Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Argentina Drugs Produced by Fermentation Engineering Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Chile Drugs Produced by Fermentation Engineering Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Colombia Drugs Produced by Fermentation Engineering Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Peru Drugs Produced by Fermentation Engineering Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Saudi Arabia Drugs Produced by Fermentation Engineering Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Israel Drugs Produced by Fermentation Engineering Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. UAE Drugs Produced by Fermentation Engineering Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Turkey Drugs Produced by Fermentation Engineering Revenue YoY Growth (US$ Million) & (2021-2032) Figure 71. Iran Drugs Produced by Fermentation Engineering Revenue YoY Growth (US$ Million) & (2021-2032) Figure 72. Egypt Drugs Produced by Fermentation Engineering Revenue YoY Growth (US$ Million) & (2021-2032) Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Monoclonal Antibodies
  • Antibiotic
  • Human Growth Hormone
  • Pharmaceutical Amino Acids
  • Insulin
  • Others
Applications
  • Hospital
  • Clinic
  • Other
Companies covered
  • Changchun GeneScience Pharmaceutical
  • Tonghua Dongbao Pharmaceutical
  • Sichuan Kelun Pharmaceutical
  • CSPC Pharmaceutical Group
  • Shanghai Shyndec Pharmaceutical
  • Shanghai Fosun Pharmaceutical
  • 3SBio Inc
  • United Laboratories International Holdings
  • Shandong Kexing Bioproducts
  • Joincare Pharmaceutical Group
  • North China Pharma
  • Harbin Pharmaceutical Group
  • Gan and Lee Pharmaceuticals
  • Anhui Anke Biotechnology

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Drugs Produced by Fermentation Engineering Market by Type
  3. 1.2.1 Global Drugs Produced by Fermentation Engineering Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Monoclonal Antibodies
  5. 1.2.3 Antibiotic
  6. 1.2.4 Human Growth Hormone
  7. 1.2.5 Pharmaceutical Amino Acids
  8. 1.2.6 Insulin
  9. 1.2.7 Others
  10. 1.3 Drugs Produced by Fermentation Engineering Market by Application
  11. 1.3.1 Global Drugs Produced by Fermentation Engineering Market Size by Application, 2021 VS 2025 VS 2032
  12. 1.3.2 Hospital
  13. 1.3.3 Clinic
  14. 1.3.4 Other
  15. 1.4 Assumptions and Limitations
  16. 1.5 Study Goals and Objectives
2 Drugs Produced by Fermentation Engineering Market Dynamics
  1. 2.1 Drugs Produced by Fermentation Engineering Industry Trends
  2. 2.2 Drugs Produced by Fermentation Engineering Industry Drivers
  3. 2.3 Drugs Produced by Fermentation Engineering Industry Opportunities and Challenges
  4. 2.4 Drugs Produced by Fermentation Engineering Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Drugs Produced by Fermentation Engineering Market Perspective (2021-2032)
  2. 3.2 Global Drugs Produced by Fermentation Engineering Growth Trends by Region
  3. 3.2.1 Global Drugs Produced by Fermentation Engineering Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Drugs Produced by Fermentation Engineering Market Size by Region (2021-2026)
  5. 3.2.3 Global Drugs Produced by Fermentation Engineering Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Drugs Produced by Fermentation Engineering Revenue by Players
  2. 4.1.1 Global Drugs Produced by Fermentation Engineering Revenue by Players (2021-2026)
  3. 4.1.2 Global Drugs Produced by Fermentation Engineering Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Drugs Produced by Fermentation Engineering Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Drugs Produced by Fermentation Engineering Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Drugs Produced by Fermentation Engineering Key Players Headquarters & Area Served
  7. 4.4 Global Drugs Produced by Fermentation Engineering Players, Product Type & Application
  8. 4.5 Global Drugs Produced by Fermentation Engineering Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Drugs Produced by Fermentation Engineering Market CR5 and HHI
  11. 4.6.3 2025 Drugs Produced by Fermentation Engineering Tier 1, Tier 2, and Tier 3
5 Drugs Produced by Fermentation Engineering Market Size by Type
  1. 5.1 Global Drugs Produced by Fermentation Engineering Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Drugs Produced by Fermentation Engineering Revenue by Type (2021-2032)
  3. 5.3 Global Drugs Produced by Fermentation Engineering Revenue Market Share by Type (2021-2032)
6 Drugs Produced by Fermentation Engineering Market Size by Application
  1. 6.1 Global Drugs Produced by Fermentation Engineering Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Drugs Produced by Fermentation Engineering Revenue by Application (2021-2032)
  3. 6.3 Global Drugs Produced by Fermentation Engineering Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Changchun GeneScience Pharmaceutical
  2. 7.1.1 Changchun GeneScience Pharmaceutical Company Information
  3. 7.1.2 Changchun GeneScience Pharmaceutical Business Overview
  4. 7.1.3 Changchun GeneScience Pharmaceutical Drugs Produced by Fermentation Engineering Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Changchun GeneScience Pharmaceutical Drugs Produced by Fermentation Engineering Product Portfolio
  6. 7.1.5 Changchun GeneScience Pharmaceutical Recent Developments
  7. 7.2 Tonghua Dongbao Pharmaceutical
  8. 7.2.1 Tonghua Dongbao Pharmaceutical Company Information
  9. 7.2.2 Tonghua Dongbao Pharmaceutical Business Overview
  10. 7.2.3 Tonghua Dongbao Pharmaceutical Drugs Produced by Fermentation Engineering Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Tonghua Dongbao Pharmaceutical Drugs Produced by Fermentation Engineering Product Portfolio
  12. 7.2.5 Tonghua Dongbao Pharmaceutical Recent Developments
  13. 7.3 Sichuan Kelun Pharmaceutical
  14. 7.3.1 Sichuan Kelun Pharmaceutical Company Information
  15. 7.3.2 Sichuan Kelun Pharmaceutical Business Overview
  16. 7.3.3 Sichuan Kelun Pharmaceutical Drugs Produced by Fermentation Engineering Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Sichuan Kelun Pharmaceutical Drugs Produced by Fermentation Engineering Product Portfolio
  18. 7.3.5 Sichuan Kelun Pharmaceutical Recent Developments
  19. 7.4 CSPC Pharmaceutical Group
  20. 7.4.1 CSPC Pharmaceutical Group Company Information
  21. 7.4.2 CSPC Pharmaceutical Group Business Overview
  22. 7.4.3 CSPC Pharmaceutical Group Drugs Produced by Fermentation Engineering Revenue and Gross Margin (2021-2026)
  23. 7.4.4 CSPC Pharmaceutical Group Drugs Produced by Fermentation Engineering Product Portfolio
  24. 7.4.5 CSPC Pharmaceutical Group Recent Developments
  25. 7.5 Shanghai Shyndec Pharmaceutical
  26. 7.5.1 Shanghai Shyndec Pharmaceutical Company Information
  27. 7.5.2 Shanghai Shyndec Pharmaceutical Business Overview
  28. 7.5.3 Shanghai Shyndec Pharmaceutical Drugs Produced by Fermentation Engineering Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Shanghai Shyndec Pharmaceutical Drugs Produced by Fermentation Engineering Product Portfolio
  30. 7.5.5 Shanghai Shyndec Pharmaceutical Recent Developments
  31. 7.6 Shanghai Fosun Pharmaceutical
  32. 7.6.1 Shanghai Fosun Pharmaceutical Company Information
  33. 7.6.2 Shanghai Fosun Pharmaceutical Business Overview
  34. 7.6.3 Shanghai Fosun Pharmaceutical Drugs Produced by Fermentation Engineering Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Shanghai Fosun Pharmaceutical Drugs Produced by Fermentation Engineering Product Portfolio
  36. 7.6.5 Shanghai Fosun Pharmaceutical Recent Developments
  37. 7.7 3SBio Inc
  38. 7.7.1 3SBio Inc Company Information
  39. 7.7.2 3SBio Inc Business Overview
  40. 7.7.3 3SBio Inc Drugs Produced by Fermentation Engineering Revenue and Gross Margin (2021-2026)
  41. 7.7.4 3SBio Inc Drugs Produced by Fermentation Engineering Product Portfolio
  42. 7.7.5 3SBio Inc Recent Developments
  43. 7.8 United Laboratories International Holdings
  44. 7.8.1 United Laboratories International Holdings Company Information
  45. 7.8.2 United Laboratories International Holdings Business Overview
  46. 7.8.3 United Laboratories International Holdings Drugs Produced by Fermentation Engineering Revenue and Gross Margin (2021-2026)
  47. 7.8.4 United Laboratories International Holdings Drugs Produced by Fermentation Engineering Product Portfolio
  48. 7.8.5 United Laboratories International Holdings Recent Developments
  49. 7.9 Shandong Kexing Bioproducts
  50. 7.9.1 Shandong Kexing Bioproducts Company Information
  51. 7.9.2 Shandong Kexing Bioproducts Business Overview
  52. 7.9.3 Shandong Kexing Bioproducts Drugs Produced by Fermentation Engineering Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Shandong Kexing Bioproducts Drugs Produced by Fermentation Engineering Product Portfolio
  54. 7.9.5 Shandong Kexing Bioproducts Recent Developments
  55. 7.10 Joincare Pharmaceutical Group
  56. 7.10.1 Joincare Pharmaceutical Group Company Information
  57. 7.10.2 Joincare Pharmaceutical Group Business Overview
  58. 7.10.3 Joincare Pharmaceutical Group Drugs Produced by Fermentation Engineering Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Joincare Pharmaceutical Group Drugs Produced by Fermentation Engineering Product Portfolio
  60. 7.10.5 Joincare Pharmaceutical Group Recent Developments
  61. 7.11 North China Pharma
  62. 7.11.1 North China Pharma Company Information
  63. 7.11.2 North China Pharma Business Overview
  64. 7.11.3 North China Pharma Drugs Produced by Fermentation Engineering Revenue and Gross Margin (2021-2026)
  65. 7.11.4 North China Pharma Drugs Produced by Fermentation Engineering Product Portfolio
  66. 7.11.5 North China Pharma Recent Developments
  67. 7.12 Harbin Pharmaceutical Group
  68. 7.12.1 Harbin Pharmaceutical Group Company Information
  69. 7.12.2 Harbin Pharmaceutical Group Business Overview
  70. 7.12.3 Harbin Pharmaceutical Group Drugs Produced by Fermentation Engineering Revenue and Gross Margin (2021-2026)
  71. 7.12.4 Harbin Pharmaceutical Group Drugs Produced by Fermentation Engineering Product Portfolio
  72. 7.12.5 Harbin Pharmaceutical Group Recent Developments
  73. 7.13 Gan and Lee Pharmaceuticals
  74. 7.13.1 Gan and Lee Pharmaceuticals Company Information
  75. 7.13.2 Gan and Lee Pharmaceuticals Business Overview
  76. 7.13.3 Gan and Lee Pharmaceuticals Drugs Produced by Fermentation Engineering Revenue and Gross Margin (2021-2026)
  77. 7.13.4 Gan and Lee Pharmaceuticals Drugs Produced by Fermentation Engineering Product Portfolio
  78. 7.13.5 Gan and Lee Pharmaceuticals Recent Developments
  79. 7.14 Anhui Anke Biotechnology
  80. 7.14.1 Anhui Anke Biotechnology Company Information
  81. 7.14.2 Anhui Anke Biotechnology Business Overview
  82. 7.14.3 Anhui Anke Biotechnology Drugs Produced by Fermentation Engineering Revenue and Gross Margin (2021-2026)
  83. 7.14.4 Anhui Anke Biotechnology Drugs Produced by Fermentation Engineering Product Portfolio
  84. 7.14.5 Anhui Anke Biotechnology Recent Developments
8 North America
  1. 8.1 North America Drugs Produced by Fermentation Engineering Revenue (2021-2032)
  2. 8.2 North America Drugs Produced by Fermentation Engineering Revenue by Type (2021-2032)
  3. 8.2.1 North America Drugs Produced by Fermentation Engineering Revenue by Type (2021-2026)
  4. 8.2.2 North America Drugs Produced by Fermentation Engineering Revenue by Type (2027-2032)
  5. 8.3 North America Drugs Produced by Fermentation Engineering Revenue Share by Type (2021-2032)
  6. 8.4 North America Drugs Produced by Fermentation Engineering Revenue by Application (2021-2032)
  7. 8.4.1 North America Drugs Produced by Fermentation Engineering Revenue by Application (2021-2026)
  8. 8.4.2 North America Drugs Produced by Fermentation Engineering Revenue by Application (2027-2032)
  9. 8.5 North America Drugs Produced by Fermentation Engineering Revenue Share by Application (2021-2032)
  10. 8.6 North America Drugs Produced by Fermentation Engineering Revenue by Country
  11. 8.6.1 North America Drugs Produced by Fermentation Engineering Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Drugs Produced by Fermentation Engineering Revenue by Country (2021-2026)
  13. 8.6.3 North America Drugs Produced by Fermentation Engineering Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Drugs Produced by Fermentation Engineering Revenue (2021-2032)
  2. 9.2 Europe Drugs Produced by Fermentation Engineering Revenue by Type (2021-2032)
  3. 9.2.1 Europe Drugs Produced by Fermentation Engineering Revenue by Type (2021-2026)
  4. 9.2.2 Europe Drugs Produced by Fermentation Engineering Revenue by Type (2027-2032)
  5. 9.3 Europe Drugs Produced by Fermentation Engineering Revenue Share by Type (2021-2032)
  6. 9.4 Europe Drugs Produced by Fermentation Engineering Revenue by Application (2021-2032)
  7. 9.4.1 Europe Drugs Produced by Fermentation Engineering Revenue by Application (2021-2026)
  8. 9.4.2 Europe Drugs Produced by Fermentation Engineering Revenue by Application (2027-2032)
  9. 9.5 Europe Drugs Produced by Fermentation Engineering Revenue Share by Application (2021-2032)
  10. 9.6 Europe Drugs Produced by Fermentation Engineering Revenue by Country
  11. 9.6.1 Europe Drugs Produced by Fermentation Engineering Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Drugs Produced by Fermentation Engineering Revenue by Country (2021-2026)
  13. 9.6.3 Europe Drugs Produced by Fermentation Engineering Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Drugs Produced by Fermentation Engineering Revenue (2021-2032)
  2. 10.2 China Drugs Produced by Fermentation Engineering Revenue by Type (2021-2032)
  3. 10.2.1 China Drugs Produced by Fermentation Engineering Revenue by Type (2021-2026)
  4. 10.2.2 China Drugs Produced by Fermentation Engineering Revenue by Type (2027-2032)
  5. 10.3 China Drugs Produced by Fermentation Engineering Revenue Share by Type (2021-2032)
  6. 10.4 China Drugs Produced by Fermentation Engineering Revenue by Application (2021-2032)
  7. 10.4.1 China Drugs Produced by Fermentation Engineering Revenue by Application (2021-2026)
  8. 10.4.2 China Drugs Produced by Fermentation Engineering Revenue by Application (2027-2032)
  9. 10.5 China Drugs Produced by Fermentation Engineering Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Drugs Produced by Fermentation Engineering Revenue (2021-2032)
  2. 11.2 Asia Drugs Produced by Fermentation Engineering Revenue by Type (2021-2032)
  3. 11.2.1 Asia Drugs Produced by Fermentation Engineering Revenue by Type (2021-2026)
  4. 11.2.2 Asia Drugs Produced by Fermentation Engineering Revenue by Type (2027-2032)
  5. 11.3 Asia Drugs Produced by Fermentation Engineering Revenue Share by Type (2021-2032)
  6. 11.4 Asia Drugs Produced by Fermentation Engineering Revenue by Application (2021-2032)
  7. 11.4.1 Asia Drugs Produced by Fermentation Engineering Revenue by Application (2021-2026)
  8. 11.4.2 Asia Drugs Produced by Fermentation Engineering Revenue by Application (2027-2032)
  9. 11.5 Asia Drugs Produced by Fermentation Engineering Revenue Share by Application (2021-2032)
  10. 11.6 Asia Drugs Produced by Fermentation Engineering Revenue by Country
  11. 11.6.1 Asia Drugs Produced by Fermentation Engineering Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Drugs Produced by Fermentation Engineering Revenue by Country (2021-2026)
  13. 11.6.3 Asia Drugs Produced by Fermentation Engineering Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Drugs Produced by Fermentation Engineering Revenue (2021-2032)
  2. 12.2 SAMEA Drugs Produced by Fermentation Engineering Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Drugs Produced by Fermentation Engineering Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Drugs Produced by Fermentation Engineering Revenue by Type (2027-2032)
  5. 12.3 SAMEA Drugs Produced by Fermentation Engineering Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Drugs Produced by Fermentation Engineering Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Drugs Produced by Fermentation Engineering Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Drugs Produced by Fermentation Engineering Revenue by Application (2027-2032)
  9. 12.5 SAMEA Drugs Produced by Fermentation Engineering Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Drugs Produced by Fermentation Engineering Revenue by Country
  11. 12.6.1 SAMEA Drugs Produced by Fermentation Engineering Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Drugs Produced by Fermentation Engineering Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Drugs Produced by Fermentation Engineering Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst